Ernie Mario

(DR. Ernest Mario Ph.D.)

Currently holds positions in Eyenovia Inc, Soleno Therapeutics Inc and Kindred Biosciences Inc

Positions
Position Company Period
Director Eyenovia Inc None -
Independent Chairman of the Board Soleno Therapeutics Inc Feb. 1, 2014 -
Independent Director Kindred Biosciences Inc April 2, 2018 -
Independent Director Celgene Corp Aug. 22, 2007 - Nov. 20, 2019
Independent Director Tonix Pharmaceuticals Holding Corp Oct. 14, 2011 - Sept. 5, 2018
Independent Chairman of the Board Chimerix Inc Feb. 1, 2013 - June 1, 2018
Independent Director Kindred Biosciences Inc Feb. 15, 2013 - May 23, 2016
Independent Director Boston Scientific Corp Oct. 30, 2001 - April 15, 2016
Lead Independent Director Pharmaceutical Product Development Inc July 1, 2009 - Jan. 1, 2016
Director XenoPort Inc June 15, 2012 - May 19, 2015
Chairman & CEO Soleno Therapeutics Inc Aug. 1, 2007 - Feb. 1, 2014
Independent Director Maxygen Inc July 20, 2001 - Aug. 29, 2013
Independent Director Vivus Inc April 18, 2012 - July 19, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
March 26, 2020 March 24, 2020
US Eyenovia Inc (EYEN)
B Purchase
82,431 +33.7%
2.27
187,118 USD
82,431 +33.7% 2.27 187,118 USD
July 15, 2019 July 11, 2019
US Eyenovia Inc (EYEN)
B Purchase
35,971 +15.2%
2.78
99,999 USD
35,971 +15.2% 2.78 99,999 USD
Feb. 14, 2019 Feb. 12, 2019
US Celgene Corp (CELG)
B Purchase
2,000 +inf%
89.99
179,980 USD
2,000 +inf% 89.99 179,980 USD
May 21, 2019 Jan. 29, 2018
US Eyenovia Inc (EYEN)
B Purchase
90,000 +61.3%
10.00
900,000 USD
90,000 +61.3% 10.00 900,000 USD
May 5, 2004 May 5, 2004
B Purchase
20,000 +39.7%
13.00
260,000 USD
20,000 +39.7% 13.00 260,000 USD
May 6, 2004 May 4, 2004
B Purchase
500 +0.5%
39.86
19,930 USD
500 +0.5% 39.86 19,930 USD
May 6, 2004 May 4, 2004
B Purchase
2,200 +2.1%
39.85
87,670 USD
2,200 +2.1% 39.85 87,670 USD